Technology area: Biotechnology & Pharmaceuticals
4 pending office actions • 2 art units • 3 examiners • 0 of 4 (0%) have an AI response strategy ready
Aldevron, LLC has 4 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 3 examiners and 2 art units, showing a portfolio distributed across technical groups with some examiner concentration.
TATGE, LEXUS MARC is the busiest examiner, with 2 pending matters. That assignment makes consistency between the related files especially relevant, while the remaining matters require responses tailored to their separate examination records.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (25%) |
| Multi-statute (no §101) | 3 (75%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TATGE, LEXUS MARC | 2 | 25.0% | +100.0% |
| AHMED, TASNIM M | 1 | 81.4% | +4.9% |
| MEYERING, SHABANA SHABBEER | 1 | 68.5% | +45.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18721403 | DEVICES AND METHODS FOR HOLLOW TISSUE ELECTROTRANSFER | AHMED, TASNIM M | — |
| 18700975 | RESPIRATORY DELIVERY OF THERAPEUTIC AGENTS | MEYERING, SHABANA SHABBEER | — |
| 18695514 | SYNTHETIC PRODUCTION OF CIRCULAR DNA VECTORS | TATGE, LEXUS MARC | — |
| 18278235 | NUCLEIC ACID VECTORS AND METHODS OF USE | TATGE, LEXUS MARC | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18700975 | RESPIRATORY DELIVERY OF THERAPEUTIC AGENTS | MEYERING, SHABANA SHABBEER | — |
| 18695514 | SYNTHETIC PRODUCTION OF CIRCULAR DNA VECTORS | TATGE, LEXUS MARC | — |
| 18278235 | NUCLEIC ACID VECTORS AND METHODS OF USE | TATGE, LEXUS MARC | — |
| Art Unit | Apps |
|---|---|
| 1637 | 2 |
| 1635 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18721403 | DEVICES AND METHODS FOR HOLLOW TISSUE ELECTROTRANSFER | AHMED, TASNIM M | — | §102§103 | Non-Final OA | — | Pending | Jun 18, 2024 |
| 18700975 | RESPIRATORY DELIVERY OF THERAPEUTIC AGENTS | MEYERING, SHABANA SHABBEER | 1635 | §102§103§112Other | Non-Final OA | — | Pending | Apr 12, 2024 |
| 18695514 | SYNTHETIC PRODUCTION OF CIRCULAR DNA VECTORS | TATGE, LEXUS MARC | 1637 | §103DP | Non-Final OA | — | Pending | Mar 26, 2024 |
| 18278235 | NUCLEIC ACID VECTORS AND METHODS OF USE | TATGE, LEXUS MARC | 1637 | §102§103§112 | Non-Final OA | — | Pending | Aug 22, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAldevron, LLC has 4 pending office actions as of October 2026, spread across 2 art units and 3 examiners.
Lexus Marc Tatge has the most, with 2 of Aldevron, LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
